| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Gilead Sciences is at the forefront of developing innovative HIV treatments, reflecting a strong commitment to advancing healthcare options for patients. The focus on novel therapies not only enhances treatment efficacy but also contributes to better patient outcomes. Additionally, the introduction of long-acting therapies represents a paradigm shift in HIV management, offering convenience and improving adherence to treatment protocols. These developments position the company as a leader in the field, driving forward the future of HIV care. |
| The price action of Gilead Sciences (GILD) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.6 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for GILD since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.8, and the negative at -0.2 on 2025-03-12. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4.7) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| GILD | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-12 | 0%(0%) | 0 | 0% | 0.6 | 4.7 | -1 | |||||||
| 2025-03-06 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-25 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-23 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-18 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-14 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-12 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-11 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-10 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| 2025-02-05 | 0%(0%) | 0 | 0% | -0.5 | -2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-09-29 00:35:36 The new data and ongoing research suggest a hopeful future in the fight against HIV, promising improved outcomes and increased efficacy of treatments. |
| 2025-09-29 00:35:36 Gilead's participation in major conferences like CROI indicates an ongoing commitment to research and development in the HIV sector. |
| 2025-09-29 00:35:36 The articles reflect a broader trend in the industry towards providing a range of treatment options for HIV patients, enhancing accessibility and personalization. |
| 2025-09-29 00:35:36 The introduction of long-acting formulations for HIV prevention and treatment indicates a significant shift towards more convenient HIV management. |
| 2025-09-29 00:35:36 The articles highlight advancements in the development of novel HIV treatment options, emphasizing Gilead's focus on innovative therapies. |